Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 90651-90700 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05134779
De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You
N/ARecruiting
400 participants
Started: Jan 12, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor2 locations
NCT05294276
Prospective Registration of Taiwan Neonatal Network (TNN)
N/ARecruiting
26,500 participants
Started: Jan 12, 2022 · Completed: Dec 31, 2050
1 condition2 sponsors1 location
NCT05201638
Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis
PHASE3Recruiting
1,050 participants
Started: Jan 12, 2022 · Completed: Oct 31, 2032
1 condition1 sponsor91 locations
NCT05069363
Whole-Body Photobiomodulation and Chronic Pain Trial
NARecruiting
20 participants
Started: Jan 12, 2022 · Completed: Sep 30, 2023
1 condition1 sponsor1 location
NCT04848870
Dental and Periodontal Status of Patients With Sjögren's Syndrome.
N/ARecruiting
100 participants
Started: Jan 12, 2022 · Completed: Jan 12, 2032
1 condition1 sponsor1 location
NCT04876781
Korean Post-marketing Surveillance for Xeljanz XR
N/ARecruiting
200 participants
Started: Jan 12, 2022 · Completed: Dec 6, 2026
3 conditions1 sponsor1 location
NCT05752656
Short- and Long-term Behavioral, Cognitive and Motor Outcomes of Frameless Deep Brain Stimulation in Patients With Parkinson's Disease: a Prospective Observational Study
N/ARecruiting
100 participants
Started: Jan 12, 2022 · Completed: Jan 1, 2034
1 condition1 sponsor1 location
NCT05389878
Implementation of a Registry for Patients with Stroke
N/ARecruiting
600 participants
Started: Jan 12, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor4 locations
NCT05123612
Maternal & Offspring Microbiome Study
NAActive, not recruiting
135 participants
Started: Jan 12, 2022 · Completed: Sep 9, 2029
4 conditions1 sponsor1 location
NCT05141253
Safety and Efficacy of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid Tumors
EARLY_PHASE1Recruiting
24 participants
Started: Jan 12, 2022 · Completed: Nov 1, 2036
1 condition2 sponsors1 location
NCT05244096
COVID-19 & Psychiatry: A Retrospective Chart Review
N/AActive, not recruiting
65,000 participants
Started: Jan 12, 2022 · Completed: Mar 30, 2025
1 condition1 sponsor1 location
NCT05305859
Venetoclax Combining Chidamide and Azacitidine (VCA) in the Treatment of R/R AML
PHASE2Recruiting
30 participants
Started: Jan 12, 2022 · Completed: Jun 30, 2027
3 conditions7 sponsors1 location
NCT05507866
Evaluation of a Comprehensive School Nutrition Enrichment Intervention (CSNEI) in Rural School Districts
NAActive, not recruiting
11,536 participants
Started: Jan 12, 2022 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT04458194
Comparing Virtual Yoga to Standard Care on Insomnia Among Cancer Survivors
NAActive, not recruiting
42 participants
Started: Jan 12, 2022 · Completed: Nov 30, 2026
1 condition2 sponsors2 locations
NCT05064631
Bacterial Lysate In Preventing Asthma
PHASE2Active, not recruiting
894 participants
Started: Jan 12, 2022 · Completed: Oct 30, 2025
3 conditions2 sponsors3 locations
NCT04966559
Effects of a Peripherally Acting µ-opioid Receptor Antagonist on Recurrent Acute Pancreatitis
PHASE2/PHASE3Active, not recruiting
74 participants
Started: Jan 12, 2022 · Completed: Jun 1, 2024
1 condition5 sponsors5 locations
NCT04813159
Remote Ischaemic Conditioning in STEMI Patients in AFRICA
NARecruiting
1,400 participants
Started: Jan 12, 2022 · Completed: Dec 31, 2027
3 conditions22 sponsors20 locations
NCT04924166
PTSD Prevention Using Oral Hydrocortisone
PHASE2Active, not recruiting
235 participants
Started: Jan 12, 2022 · Completed: Sep 30, 2025
3 conditions3 sponsors3 locations
NCT04979078
Photobiomodulation Therapy in the Management of Hand-foot Syndrome and Hand-foot Skin Reaction
NARecruiting
40 participants
Started: Jan 12, 2022 · Completed: Aug 31, 2029
2 conditions2 sponsors2 locations
NCT05504213
A Phase Ib Study of HS-10352 Plus Fulvestrant in Patients With Advanced Breast Cancer
PHASE1Recruiting
224 participants
Started: Jan 12, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04615819
Access to Kidney Transplantation in Minority Populations
NARecruiting
398 participants
Started: Jan 11, 2022 · Completed: Dec 31, 2026
1 condition4 sponsors1 location
NCT06451029
Prevention of Smoking Related Diseases
N/ARecruiting
189 participants
Started: Jan 11, 2022 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT06271733
TMS for Veterans Attending a 2-week Intensive Outpatient Program for PTSD
NAActive, not recruiting
30 participants
Started: Jan 11, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05636709
National GMA Post-market Clinical Follow-up Study (GRACE)
N/ARecruiting
350 participants
Started: Jan 11, 2022 · Completed: Jun 30, 2026
2 conditions1 sponsor30 locations
NCT05341986
Optimizing Stroke Prophylaxis of Acute Atrial Fibrillation With an Electronic Clinical Decision Support Tool
NAEnrolling by invitation
36 participants
Started: Jan 11, 2022 · Completed: May 1, 2026
1 condition1 sponsor1 location
NCT05307055
Evaluation of Neurocognitive Changes in Parkinson's Disease After Low Frequency Burst Stimulation
NARecruiting
40 participants
Started: Jan 11, 2022 · Completed: Aug 31, 2029
1 condition1 sponsor1 location
NCT05081609
A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies
PHASE1/PHASE2Recruiting
345 participants
Started: Jan 11, 2022 · Completed: Aug 31, 2029
13 conditions1 sponsor69 locations
NCT05065801
Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients
PHASE2Recruiting
162 participants
Started: Jan 11, 2022 · Completed: Oct 30, 2027
1 condition1 sponsor8 locations
NCT05272176
Veterans Coordinated Community Care (3C) Study
NAActive, not recruiting
850 participants
Started: Jan 11, 2022 · Completed: Dec 31, 2025
1 condition5 sponsors7 locations
NCT06714747
Soft Tissue Prediction in Orthognathic Surgery by Making Anatomically Accurate Virtual Model
N/ARecruiting
10 participants
Started: Jan 11, 2022 · Completed: Nov 11, 2026
1 condition1 sponsor1 location
NCT04857788
Program of Digital Accompaniment to Optimize Homework Performances and Increase Familial Quality of Life in 9 to 16 Years Children With ADHD
NAActive, not recruiting
264 participants
Started: Jan 11, 2022 · Completed: Mar 15, 2024
1 condition1 sponsor9 locations
NCT05386277
A PMCF Study to Confirm the Performance and Safety of the LeMaitre® TufTex Single Lumen Embolectomy Catheter
NARecruiting
112 participants
Started: Jan 11, 2022 · Completed: Jun 30, 2027
1 condition2 sponsors3 locations
NCT05181462
Nadunolimab in Combination with Gemcitabine Plus Carboplatin in Patients with Advanced Triple Negative Breast Cancer.
PHASE1/PHASE2Active, not recruiting
117 participants
Started: Jan 11, 2022 · Completed: Aug 31, 2026
1 condition2 sponsors23 locations
NCT04938609
Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC)
PHASE2Active, not recruiting
28 participants
Started: Jan 11, 2022 · Completed: Jan 11, 2031
2 conditions2 sponsors3 locations
NCT06054256
Effects of Digitally Delivered and Group-based CBT-I in Pregnant Women With Comorbid Insomnia and Depression
NARecruiting
144 participants
Started: Jan 11, 2022 · Completed: Dec 31, 2025
3 conditions3 sponsors1 location
NCT05089084
Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS)
PHASE3Active, not recruiting
75 participants
Started: Jan 11, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor58 locations
NCT05223647
Chemo-immunotherapy Plus Thoracic Radiotherapy in Extensive Stage Small-cell Lung Cancer
PHASE3Recruiting
302 participants
Started: Jan 11, 2022 · Completed: Oct 31, 2029
1 condition21 sponsors20 locations
NCT04859946
Itacitinib for the Prevention of Graft Versus Host Disease
PHASE2Active, not recruiting
31 participants
Started: Jan 11, 2022 · Completed: Apr 1, 2027
1 condition2 sponsors1 location
NCT05122897
Investigation of Biofilm Formation on Temporary push-on Rings of Implant Crowns
NARecruiting
33 participants
Started: Jan 11, 2022 · Completed: Feb 28, 2026
3 conditions2 sponsors1 location
NCT05178238
Intestinal Microbiota of Patients Hospitalized With Sars-CoV-2
N/AActive, not recruiting
15 participants
Started: Jan 11, 2022 · Completed: Jan 31, 2025
1 condition1 sponsor1 location
NCT05185141
Respiratory Variation of Carotid Doppler Peak Velocity (CDPV) for Non-invasive Prediction of Fluid Responsiveness
N/ARecruiting
84 participants
Started: Jan 11, 2022 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT05217628
An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients With Trigeminal Neuralgia.
PHASE2/PHASE3Active, not recruiting
166 participants
Started: Jan 11, 2022 · Completed: Feb 1, 2027
1 condition1 sponsor34 locations
NCT05236348
Performance of the Aktiia Optical Blood Pressure Monitoring Device Against Double Auscultation
NARecruiting
225 participants
Started: Jan 11, 2022 · Completed: Mar 31, 2025
3 conditions1 sponsor1 location
NCT06391671
The Stress-obesity Axis: a Metabolomics Approach Towards Personalized Nutrition in Adolescents
N/ARecruiting
750 participants
Started: Jan 11, 2022 · Completed: Jul 31, 2027
1 condition1 sponsor7 locations
NCT05156294
Effect of Soft Tissue Augmentation With an Acellular Dermal Matrix in Marginal Bone Levels Around Implants
PHASE3Active, not recruiting
30 participants
Started: Jan 10, 2022 · Completed: Aug 10, 2024
1 condition1 sponsor1 location
NCT06126692
3TR Asthma Biologics Cohort (ABC) Study
N/ARecruiting
600 participants
Started: Jan 10, 2022 · Completed: Aug 31, 2033
1 condition5 sponsors2 locations
NCT04943848
rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
PHASE1Recruiting
36 participants
Started: Jan 10, 2022 · Completed: Dec 31, 2025
2 conditions4 sponsors3 locations
NCT05254821
Cell-free Tumor DNA as Minimal Residual Disease in Hodgkin Lymphoma Patients
N/ARecruiting
130 participants
Started: Jan 10, 2022 · Completed: Feb 3, 2026
1 condition1 sponsor1 location
NCT04521803
High vs. Standard Dose Rifampicin for Effusive Tuberculous Pericarditis
PHASE2Recruiting
60 participants
Started: Jan 10, 2022 · Completed: Feb 28, 2026
2 conditions1 sponsor2 locations
NCT05011149
Selective Early Medical Treatment of Patent Ductus Arteriosus in Extremely Low Gestational Age Infants: A Pilot RCT
PHASE3Recruiting
100 participants
Started: Jan 10, 2022 · Completed: Sep 30, 2024
1 condition11 sponsors9 locations